Health News Stories
Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.
For further exploration, delve into our comprehensive Health and Food Corruption Information Center.
Johns Hopkins Medicine announced the launch of the Center for Psychedelic and Consciousness Research, to study compounds like LSD and psilocybin for a range of mental health problems, including anorexia, addiction and depression. The center is the first of its kind in the country, established with $17 million in commitments from wealthy private donors and a foundation. The centers at Johns Hopkins and Imperial College give psychedelic medicine, as some call it, a long-sought foothold in the scientific establishment. Since the early 2000s, several scientists have been exploring the potential of psychedelics and other recreational drugs for psychiatric problems, and their early reports have been tantalizing. The emergence of depression treatment with the anesthetic and club drug ketamine and related compounds, which cause out-of-body sensations, also has piqued interest in mind-altering agents as aids to therapy. The ... funding will help clarify which drugs help which patients. Roland Griffiths, a neuroscientist at Johns Hopkins who will direct the new center ... said the new funds will cover six full-time faculty, five postdoctoral scientists and the costs of running trials. Among the first of those trials are a test of psilocybin for anorexia nervosa and of psilocybin for psychological distress and cognitive impairment in early Alzheimers disease. The one thats crying out to be done is for opiate-use disorder, and we also plan to look at that, Dr. Griffiths said.
Note: Learn about the fascinating man who is bankrolling a significant portion of this new center in this New York Times article. For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.
Jada Renee Louis of Newport News, Virginia, died on 22 June 2019 about a week after requiring emergency hospital care for diabetic ketoacidosis, a serious complication caused by a lack of insulin, and a foot ulcer. She was 24. A type 1 diabetic, Louis, who did not have health insurance coverage, couldnt afford the cost of her insulin doses and pay her rent. She chose to skip doses in order to pay her rent. Today a vial of insulin which will last 28 days once opened costs about $300 in the US. People are literally dying over $300 like my sister did. People shouldnt have to choose between medications or shelter. Thats the most outrageous decision for somebody to have to make, yet people are doing it daily, Jazmine Baldwin, Louiss sister, [said]. Price gouging of insulin and other barriers to accessing it are symptomatic of Americas broken healthcare system, diabetes advocates argue, and the resulting deaths and struggles of those with diabetes demonstrate the need for systemic reforms. Between 2012 to 2016, the average cost of insulin in the United States nearly doubled to $5,705 per year for individuals with type 1 diabetes. Production costs for a vial of insulin are estimated to cost around $5 while pharmaceutical companies charge as high as $540 per vial and Americans are dying as a result of being unable to afford it in addition to the expensive costs of medical care, and supplies such as syringes and glucose monitors. Some 1.25 million Americans are currently diagnosed with type 1 diabetes.
Note: For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption from reliable major media sources.
The American Heart Association and the American College of Cardiology released new guidelines for prescribing cholesterol-lowering medicines. The big winners are expected to be the drug makers that sell statins, since other types of pills were not recommended. Of the 15 panelists that authored these new guidelines, six reported having recent or current ties to drugmakers that already sell or are developing cholesterol medications. And among the half dozen who disclosed these relationships was one of the two panel co-chairs, which contradicts an Institute of Medicine suggestion about managing conflicts and leadership roles on such panels. To be specific, the Institute of Medicine wrote that, whenever possible, guideline development group members should not have conflicts of interest ... and the chair or co-chairs should not be a person(s) with conflicts of interest. The Institute of Medicine also wrote that members with conflicts should not represent a majority (here is the IOM report). One of the reasons the IOM recently recommended eliminating rather than managing financial conflicts of interest in guideline development groups is because of concerns about implicit bias, says Lisa Cosgrove ... at the University of Massachusetts. When individuals have commercial ties they are vulnerable to developing subtle, but sometimes powerful, pro-industry ways of thinking. Transparency ... can actually worsen the problem, because some people think simply disclosing a tie relieves any moral concern.
Note: For lots more on this, see an informative article titled "The Statin Mafia Censors Pharmaceutical Harm." For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption from reliable major media sources.
The global insulin market is dominated by three companies: Eli Lilly, the French company Sanofi and the Danish firm Novo Nordisk. All three have raised list prices to similar levels. According to IBM Watson Health data, Sanofis popular insulin brand Lantus was $35 a vial when it was introduced in 2001; its now $270. Novo Nordisks Novolog was priced at $40 in 2001, and as of July 2018, its $289. The companies appear to have increased [prices] in lockstep over a number of years, prompting allegations of price fixing. All three companies denied these charges. (In 2010, Mexico fined Eli Lilly and three Mexican companies for price collusion on insulin, an allegation Eli Lilly also denied.) In the United States, a federal prosecutor and at least five state attorneys general are currently investigating the companies pricing practices. There is also another, less known corporate entity in the mix: pharmacy benefit managers (PBMs), which include Express Scripts, OptumRx and CVS Health; all are now named in lawsuits on high insulin prices. These corporate entities are powerful special interests. In 2017, the pharmaceutical and health product industry ... spent nearly $280 million on lobbying, the biggest spender by far of 20 top industries, according to the Center for Responsive Politics. The industry also has a revolving door to government. Alex Azar, the head of the Department of Health and Human Services, was the president of Eli Lillys U.S. division until 2017.
Note: For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption from reliable major media sources.
McKrae Game wants people to know that he was wrong about all of it. He was wrong to found Hope for Wholeness Network, a faith-based conversion therapy program that seeks to rid people of their LGBTQ identities. He was wrong to create a slogan promoting the idea of freedom from homosexuality through Jesus Christ. He was wrong to tell people they were doomed for all eternity if they didnt change their ways. After 20 years working in that field, Game said he realizes the harm he has caused and that he, himself, is gay. Conversion therapy encompasses a widely discredited range of methods that purport to change someones sexual orientation or gender identity. The practice is illegal in 18 states and the District. Its all in my past, but many, way TOO MANY continue believing that there is something wrong with themselves and wrong with people that choose to live their lives honestly and open as gay, lesbian, trans, etc., Game, 51, wrote on Facebook last week. The very harmful cycle of self shame and condemnation has to stop. Game is among many founders and leaders of conversion therapy programs to disavow the practice later. In 2014, nine former ex-gay leaders signed an open letter denouncing conversion therapy as ineffective and harmful and calling for an end to it. Leaders of conversion therapy programs rarely renounce the practice publicly because doing so involves turning their backs not just on the ex-gay community, but also on conservative faith as a whole.
Note: For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.
Dena Churchill says that if the price for sharing her health "truths" is a $100,000 fine and losing her career, it's a price she's willing to accept. The former Halifax-based chiropractor surrendered her licence and admitted to charges of professional incompetence following a lengthy investigation by the Nova Scotia College of Chiropractors, all prompted by Churchill's persistent sharing of views on vaccines. CBC News began reporting on the complaints against Churchill in 2018, but she has declined to speak publicly until now. In a recent interview, Churchill said she believes there is a distinction between what she was posting on personal social media pages and what she was doing in her professional capacity. She said she felt "assaulted" that her professional governing body could mandate and govern her personal views. "I didn't want to take [the posts] down," she said. "This whole issue is not about what I was doing in my practice or what I was promoting in my practice ... I was reprimanded on my own personal views and wanting to share it with the people I love." Churchill said the information she was sharing was intended for just a few family members, although she also compared what she was doing to living in a building she discovered had arsenic in the water system. "I'd go knock on every door in that building to let them know because I would feel a human desire to help and to share information," she said.
Note: NBC also reports email service provider Mailchimp has removed several anti-vaccination activists from its platform and will no longer provide services to newsletters that push anti-vaccination content. Is this an assault on free speech? For more along these lines, see concise summaries of deeply revealing news articles on vaccines from reliable major media sources.
New research finds that individuals with higher optimism tend to live longer and also have greater odds of living 85 years and more. A recent PNAS paper describes how the researchers assessed the link between higher optimism and longer lifespan, with a particular focus on the chances of reaching "exceptional longevity." The team carried out the study because most research on exceptional longevity has tended to focus on the effect of "biomedical factors." More recently, however, scientists have become interested in the role of nonbiological factors. "While research has identified many risk factors for diseases and premature death," says first and corresponding author Lewina O. Lee, Ph.D., "we know relatively less about positive psychosocial factors that can promote healthy aging." She and her colleagues defined optimism as the "general expectation that good things will happen or the belief that the future will be favorable because one can control important outcomes." For the analysis, the team brought together data on 69,744 females ... and 1,429 males. The questionnaires that they completed ... included items on optimism. When the researchers analyzed the data, they found that the females and males with the highest levels of optimism ... lived on average 1115% longer than those with the lowest levels of optimism. In addition, [those] with the highest levels of optimism had a 5070% greater likelihood of living until their 85th birthday and beyond.
Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.
Americas agricultural landscape is now 48 times more toxic to honeybees, and likely other insects, than it was 25 years ago, almost entirely due to widespread use of so-called neonicotinoid pesticides, according to a new study published today in the journal PLOS One. This enormous rise in toxicity matches the sharp declines in bees, butterflies, and other pollinators as well as birds, says co-author Kendra Klein. This is the second Silent Spring. Neonics are like a new DDT, except they are a thousand times more toxic to bees than DDT was, Klein says. Using a new tool that measures toxicity to honey bees, the length of time a pesticide remains toxic, and the amount used in a year, Klein and researchers from three other institutions determined that the new generation of pesticides has made agriculture far more toxic to insects. Honey bees are used as a proxy for all insects. The study found that neonics accounted for 92 percent of this increased toxicity. Neonics are not only incredibly toxic to honeybees, they can remain toxic for more than 1,000 days in the environment, said Klein. Some scientists have been warning that there is an insect apocalypse underway. A global analysis of 452 species in 2014 estimated that insect abundance had declined 45 percent over 40 years. Not only do bees, butterflies, and other insects pollinate one-third of all food crops, declining insect numbers can also have catastrophic ecological repercussions.
Note: For more along these lines, see concise summaries of deeply revealing news articles on food system corruption from reliable major media sources.
The Apple iPhone 7 was set to operate at full power and secured below a tub of clear liquid, specially formulated to simulate human tissue. For 18 minutes, [a probe] repeatedly measured the amount of radiofrequency radiation the liquid was absorbing from the cellphone. This test, which was paid for by the Tribune and conducted according to federal guidelines at an accredited lab, produced a surprising result: Radiofrequency radiation exposure from the iPhone 7 one of the most popular smartphones ever sold measured over the legal safety limit and more than double what Apple reported to federal regulators from its own testing. The Federal Communications Commission, which is responsible for regulating phones, states on its website that if a cellphone has been approved for sale, the device will never exceed the maximum allowable exposure limit. But this phone, in an independent lab inspection, had done exactly that. In all, 11 models from four companies were tested, with varying results. The Tribune asked its lab to conduct a second phase of testing, placing the phones 2 millimeters away from the simulated body. The 2-millimeter distance was chosen to estimate the potential exposure for an owner carrying the phone in a pants or shirt pocket. Under those conditions, most of the models tested yielded results that were over the exposure limit, sometimes far exceeding it. At 2 millimeters, the results from a Samsung Galaxy S8 were more than five times the standard.
Note: For more along these lines, see concise summaries of deeply revealing news articles on the risks and dangers of wireless technologies from reliable major media sources.
Jack Tibbetts, a member of the Santa Rosa, Calif., city council, knew he had a problem. It was early 2018, and hed started getting calls from constituents at opposite ends of the political spectrum. The common thread: cellular antennas going up next to their homes, causing concerns over property values and health. Cities and towns throughout Northern California are issuing ordinances that would exclude new 5G cell sites from residential areas, citing ... health concerns. Residents of Portland, Ore., and Whitefish, Mont., have also cited these beliefs while lobbying for restrictions. Legislators in four states including New Hampshire have proposed bills that would mandate further study of health effects or else urge Congress to do so, and Congressman Thomas Suozzi (D., N.Y.) wrote to the FCC echoing these concerns. For Mr. Tibbetts, it didnt matter whether or not these new small cell antennas ... going up in Santa Rosa were actually dangerous. What mattered was that his constituents didnt want these ungainly chunks of public infrastructure anywhere near them. Whatever the basis for residents objections to new cell towers, Mr. Tibbetts - as well as countless mayors, governors and council members across the country - have little or no power under current rules to act on their constituents wishes. Those who do take action are creating ordinances that put their cities at risk of being sued by the telecoms, as happened this month in Rochester, N.Y..
Note: You can find the full article on this webpage. For more along these lines, see concise summaries of deeply revealing news articles on the risks and dangers of wireless technologies from reliable major media sources.
A judge Monday found Johnson & Johnson responsible for fueling Oklahomas opioid crisis, ordering the health-care company to pay $572 million to remedy the devastation wrought by the epidemic on the state and its residents. Cleveland County District Judge Thad Balkmans landmark decision is the first to hold a drugmaker culpable for the fallout of years of liberal opioid dispensing that began in the late 1990s. More than 400,000 people have died of overdoses from painkillers, heroin and illegal fentanyl since 1999. With more than 40 states lined up to pursue similar claims against the pharmaceutical industry, the ruling ... could influence both sides strategies in the months and years to come. Plaintiffs attorneys around the country cheered the decision, saying they hoped it would be a model for an enormous federal lawsuit brought by nearly 2,000 cities, counties, Native American tribes and others scheduled to begin in Cleveland, Ohio, in October. Johnson & Johnsons products ... were a small part of the painkillers consumed in Oklahoma. But Hunter painted the company as an industry kingpin because two other companies it owned had grown, processed and supplied 60 percent of the ingredients in painkillers sold by most drug companies. At the root of this crisis was Johnson & Johnson, a company that literally created the poppy that became the source of the opioid crisis, the state charged. The state also said the health-care giant actively took part in ... an aggressive misinformation campaign.
Note: For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption from reliable major media sources.
In a direct challenge to California regulators and Bay Area environmentalists, the Trump administration Thursday ordered companies to ignore state requirements that businesses warn customers if their products contain glyphosate, a weed killer that has been linked to cancer. The decision flies in the face of three California court rulings against Monsanto, which markets the chemical as Roundup. The agricultural giant faces more than 13,000 suits nationwide by users of Roundup, the worlds best-selling herbicide. The U.S. Environmental Protection Agency announced it would no longer approve labels saying glyphosate is known to cause cancer. The state requires companies to warn customers about chemicals known to cause cancer under the Safe Drinking Water and Toxic Enforcement Act. Glyphosate was classified as a probable human carcinogen in 2015 by the International Agency for Research on Cancer, which is part of the World Health Organization. Lawyers for sick clients who were awarded tens of millions of dollars after suing Monsanto introduced evidence that glyphosate can cause genetic damage that leads to non-Hodgkins lymphoma. They claimed Monsanto ignored that information and published information ghost written by staffers denying the toxicity of the chemical. Superior Court Judge Winifred Smith said there was clear evidence that Monsanto, after learning of the dangers, made efforts to impede, discourage or distort scientific inquiry by regulators.
Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.
Monsanto operated a fusion center to monitor and discredit journalists and activists, and targeted a reporter who wrote a critical book on the company, documents reveal. The records reviewed by the Guardian show Monsanto adopted a multi-pronged strategy to target Carey Gillam, a Reuters journalist who investigated the companys weedkiller and its links to cancer. Monsanto, now owned by the German pharmaceutical corporation Bayer, also monitored a not-for-profit food research organization through its intelligence fusion center, a term that the FBI and other law enforcement agencies use for operations focused on surveillance and terrorism. The documents, mostly from 2015 to 2017, were disclosed as part of an ongoing court battle on the health hazards of the companys Roundup weedkiller. Monsanto planned a series of actions to attack a book authored by Gillam prior to its release, including ... directing industry and farmer customers on how to post negative reviews. Monsanto paid Google to promote search results for Monsanto Glyphosate Carey Gillam that criticized her work. Monsanto fusion center officials wrote a lengthy report about singer Neil Youngs anti-Monsanto advocacy. The internal records dont offer significant detail on the activities or scope of the fusion center, but ... government fusion centers have increasingly raised privacy concerns surrounding the way law enforcement agencies collect data, surveil citizens and share information.
Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and media manipulation from reliable major media sources.
Spending hours on smartphones and tablet devices has frequently been linked to exacerbating mental wellbeing, but new research claims the damage might start in users as young as two. After just one hour of screen time, children and adolescents may have less curiosity, lower self-control and lower emotional stability, which can lead to an increased risk of anxiety and depression, claims a US study published in the journal Preventive Medicine Reports. The researchers found that those aged 14 to 17 are more at risk for such adverse effects, but noticed the correlations in younger children and toddlers, whose brains are still developing, as well. The study found that nursery school children who used screens frequently were twice as likely to lose their temper. It also claimed that nine per cent of those aged 11 to 13 who spent an hour a day on screens were not curious in learning new things, a figure which rose to 22.6 per cent for those whose screen time was seven hours a day or more. Authors Professor Jean Twenge, of San Diego State University, and Professor Keith Campbell, of the University of Georgia, said: "Half of mental health problems develop by adolescence. "Thus, there is an acute need to identify factors linked to mental health issues that are amenable to intervention in this population, as most antecedents are difficult or impossible to influence. "Compared to these more intractable antecedents of mental health, how children and adolescents spend their leisure time is more amenable to change."
Note: For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.
Three pharmaceutical companies collectively are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high, California Attorney General Xavier Becerra said. The bulk of the money will come from Teva Pharmaceutical Industries Ltd. and its affiliates for paying to delay a generic narcolepsy drug, Provigil, from entering the market for nearly six years. Teva is paying $69 million, which Becerra says is the largest pay-for-delay settlement received by any state. Such agreements let the developer of brand name drugs keep their monopolies over the drugs after their patents expire, thereby letting them continue to charge consumers higher prices. The drug developer pays the generic manufacturer to keep the cheaper version of the drug from entering the marketplace for an agreed period of time. Such agreements can force consumers and the health care market to pay as much as 90% more than if there were generic alternatives. More than $25 million of the settlement will go to a consumer fund for California residents who purchased Provigil, Nuvigil or Modafinil between 2006 and 2012. The second, $760,000 settlement is with Teva, Endo Pharmaceuticals and Teikoku Pharma USA over keeping a genetic alternative to the pain patch Lidoderm from entering the market for nearly two years. Both settlements bar the companies from pay-for-delay agreements for several years.
Note: They are only barred from pay-for-delay agreements for several years? Shouldn't this practice be illegal? For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption from reliable major media sources.
Scientists have long found a possible link between anticholinergic drugs and an increased risk of dementia. A study published in the journal JAMA Internal Medicine on Monday suggests that the link is strongest for certain classes of anticholinergic drugs - particularly antidepressants such as paroxetine or amitriptyline, bladder antimuscarinics such as oxybutynin or tolterodine, antipsychotics such as chlorpromazine or olanzapine and antiepileptic drugs such as oxcarbazepine or carbamazepine. Researchers wrote in the study that "there was nearly a 50% increased odds of dementia" associated with a total anticholinergic exposure of more than 1,095 daily doses within a 10-year period, which is equivalent to an older adult taking a strong anticholinergic medication daily for at least three years, compared with no exposure. The researchers found only an association between anticholinergic drugs and dementia risk, not a causal relationship. "However, if this association is causal, the population-attributable fractions indicate that around 10% of dementia diagnoses are attributable to anticholinergic drug exposure, which would equate, for example, to around 20,000 of the 209,600 new cases of dementia per year in the United Kingdom," the researchers wrote in the study. It has been well known that anticholinergic agents and confusion or memory issues are linked, but the new study investigated this association over a long period of time, said Dr. Douglas Scharre ... at the Ohio State University Wexner Medical Center.
Note: For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.
In May 2008, as the opioid epidemic was raging in America, a representative of the nations largest manufacturer of opioid pain pills sent an email to a client at a wholesale drug distributor in Ohio. Victor Borelli, a national account manager for Mallinckrodt, told Steve Cochrane, the vice president of sales for KeySource Medical, to check his inventories and [i]f you are low, order more. If you are okay, order a little more, Capesce? Then Borelli joked, destroy this email ... Is that really possible? Oh Well... Those email excerpts are quoted in a 144-page plaintiffs filing along with thousands of pages of documents unsealed by a judges order Friday in a landmark case in Cleveland against many of the largest companies in the drug industry. A Drug Enforcement Administration database released earlier in the week revealed that the companies had inundated the nation with 76 billion oxycodone and hydrocodone pills from 2006 through 2012. Nearly 2,000 cities, counties and towns are alleging that the companies knowingly flooded their communities with opioids, fueling an epidemic that has killed more than 200,000. The filing by plaintiffs depict some drug company employees as driven by profits and undeterred by the knowledge that their products were wreaking havoc across the country. Plaintiffs in the case argue that the actions of some of Americas biggest and best-known companies - including Mallinckrodt, Cardinal Health, McKesson, Walgreens, CVS, Walmart and Purdue Pharma - amounted to a civil racketeering enterprise.
Note: For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption from reliable major media sources.
The origin, evolution and astonishing scale of Americas catastrophic opioid epidemic just got a lot clearer. The drug industry - the pill manufacturers, wholesalers and retailers - found it profitable to flood some of the most vulnerable communities in America with billions of painkillers. They continued to move their product, and the medical community and government agencies failed to take effective action, even when it became apparent that these pills were fueling addiction and overdoses and were getting diverted to the streets. This has been broadly known for years, but this past week, the more precise details became public for the first time. The revelatory data comes from the Drug Enforcement Administration and its Automation of Reports and Consolidated Orders System (ARCOS). This really shows a relationship between the manufacturers and the distributors: They were all in it together, said Jim Geldhof, a retired DEA employee. Were seeing a lot of internal stuff that basically confirms ... that it was all about greed, and all about money. The data shows a trend in pill distribution that, according to the lawsuit plaintiffs, cant be passed off as reasonable therapeutic medical treatment. The industry shipped 76 billion oxycodone and hydrocodone pills across the country from 2006 through 2012, the period covered by the ARCOS data released this past week. These pills didnt flow in a steady stream but were more like a flash flood, spiking from 8.4 billion in 2006 to 12.6 billion in 2012.
Note: For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption from reliable major media sources.
Last week, the U.S. House of Representatives quietly passed a bill requiring the Inspector General of the Department of Defense (DoD) to conduct a review into whether the Pentagon experimented with ticks and other blood-sucking insects for use as biological weapons between 1950 and 1975. If the Inspector General finds that such experiments occurred, then, according to the bill, they must provide the House and Senate Armed Services committees with a report on the scope of the research and "whether any ticks or insects used in such experiments were released outside of any laboratory by accident or experiment design," potentially leading to the spread of diseases such as Lyme. The amendment was put forward by Rep. Chris Smith, a Republican from New Jersey, who was "inspired" by several books and articles claiming that the U.S. government had conducted research at facilities such as Fort Detrick, Maryland, and Plum Island, New York, for this purpose. One of the books that Smith refers to - called Bitten: The Secret History of Lyme Disease and Biological Weapons ... features interviews with late Swiss-born scientist Willy Burgdorfer - the man credited with discovering the bacterial pathogen that causes Lyme disease - who once worked for the DoD as a bioweapons specialist. "Those interviews ... suggest that he and other bioweapons specialists stuffed ticks with pathogens to cause severe disability, disease - even death - to potential enemies," Smith said.
Note: See a good video on this. For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.
Hallucination-inducing drugs like magic mushrooms could be about to break big pharmas stranglehold on the hugely lucrative market for antidepressants, according to the head of the worlds first centre for psychedelic research. Antidepressant prescriptions have doubled in England in a decade with around seven million adults taking the drugs, and the global market is predicted to be worth $15.9bn (12.5bn) by 2023. At Imperial College London, Dr Robin Carhart-Harris is leading one of the first trials to test how therapy using psilocybin mushrooms, which are currently banned in the UK, compares to leading antidepressants. While he wont prejudge the results of the study, he says participants describe a cathartic emotional release with psilocybin therapy the polar opposite of antidepressants, which patients complain leave their emotions, whether positive or negative, blunted. It is the first of many studies planned under the banner of the new Centre for Psychedelic Research at Londons Imperial College. Dr James Rucker is another of those researching the potential benefits of psychedelics ... at Kings College London. The Kings team are launching two trials, one looking at whether psilocybin therapy can help people whose depression is resistant to treatment with conventional antidepressants. He says it was possible the drug could be licensed in five years.
Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.
Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
